

<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xmlns:xlink="https://www.w3.org/1999/xlink">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Avicenna J Med Biotech</journal-id>
      <journal-id journal-id-type="publisher-id">arij002</journal-id>
      <journal-title-group>
        <journal-title>Avicenna Journal of Medical Biotechnology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2008-2835</issn>
      <issn pub-type="epub">2008-4625</issn>
      <publisher>
        <publisher-name>Avicenna Research Institute</publisher-name>
      </publisher>
    </journal-meta>

    <article-meta>
      <article-id pub-id-type="publisher-id">ajmb239</article-id>
      <article-id pub-id-type="doi"></article-id>
      <article-id pub-id-type="pmid"></article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
             <subject></subject> 
        </subj-group>
        <subj-group>
            <subject></subject>
        </subj-group> 
      </article-categories>
      <title-group>
        <article-title>LC-MS Method for Studying the Pharmacokinetics and Bioequivalence of Clonidine Hydrochloride in Healthy Male Volunteers</article-title>
      </title-group>
        <contrib-group><contrib contrib-type="author"><name><surname>Danafar</surname><given-names>Hossein</given-names></name></contrib><aff>Tehran University of Medical Sciences, Tehran, Iran</aff></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Hamidi</surname><given-names>Mehrdad</given-names></name></contrib><aff>Tehran University of Medical Sciences, Tehran, Iran</aff></contrib-group>
      <pub-date pub-type="ppub">
        <day></day>
        <month></month>
        <year></year>
      </pub-date>
      <pub-date pub-type="epub">
        <day></day>
        <month></month>
        <year></year>
      </pub-date>
      <volume>8</volume>
      <issue>2</issue>
      <fpage>91</fpage>
      <lpage>98</lpage>
      <history>
        <date date-type="received">
          <day>11</day>
          <month>11</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>13</day>
          <month>1</month>
          <year>2016</year>
        </date>
      </history>
      <abstract>
      <p>
      &lt;p&gt;Background: A simple and sensitive high performance liquid chromatography-electrospray ionization mass spectrometry method has been evaluated for the assignment of clonidine hydrochloride in human plasma.&lt;br /&gt;
Methods: The mobile phase composed of acetonitrile-water 60:40 (&lt;em&gt;v/v&lt;/em&gt;) and 0.2% formic acid 20&lt;em&gt; &amp;micro;l&lt;/em&gt; of sample was chromatographically analyzed using a repacked ZORBAX-XDB-ODS C&lt;sub&gt;18&lt;/sub&gt; column (2.1 &lt;em&gt;mm&lt;/em&gt;x30 &lt;em&gt;mm&lt;/em&gt;, 3.5 &lt;em&gt;&amp;mu;&lt;/em&gt;). Detection of analytes was achieved by tandem mass spectrometry with Electrospray Ionization (ESI) interface in positive ion mode operated under the multiple-reaction monitoring mode (m/z 230.0 &amp;rarr;213). Sample pretreatment consisted of a one-step Protein Precipitation (PPT) with methanol and perchloric acid (HClO&lt;sub&gt;4&lt;/sub&gt;) of 0.10 &lt;em&gt;ml&lt;/em&gt; plasma.&lt;br /&gt;
Results: Standard curve was linear (r=0.998) over the concentration range of 0.01-10.0 &lt;em&gt;ng/ml&lt;/em&gt; and showed suitable accuracy and precision. The Limit of Quantification (LOQ) was 0.01 &lt;em&gt;ng/ml&lt;/em&gt;. The mean (SD) Cmax, Tmax, AUC&lt;sub&gt;0&amp;ndash;t &lt;/sub&gt;and AUC&lt;sub&gt;0&amp;ndash;&amp;infin;&lt;/sub&gt; values after administration of the test and reference formulations, respectively, were in this manner: 6.16 (0.32) versus 6.21 (0.07) &lt;em&gt;ng/ml&lt;/em&gt;, 30.12 (0.86) versus 30.13 (0.73) &lt;em&gt;hr&lt;/em&gt;, 290.37 (1.13) versus 293.39 (1.22) &lt;em&gt;ng/ml/hr&lt;/em&gt;, and 350.17 (1.98) versus 352.96 (1.67) &lt;em&gt;ng/ml/hr&lt;/em&gt;. The mean (SD) t1/2 was 120.12 (1.90) &lt;em&gt;hr&lt;/em&gt; for the test formulation and 120.96 (1.54) hr for the reference formulation. No statistical differences were showed for Cmax and the area under the plasma concentration-time curve for test and reference tablets.&lt;br /&gt;
Conclusion: The method is rapid, simple, very steady and precise for the separation, assignment, pharmacokinetic and bioavailability evaluation of clonidine in healthy Iranian adult male volunteers.&lt;/p&gt;

      </p>
      </abstract>
    </article-meta>
  </front>
    
</article>
